Efluelda Tetra

Efluelda Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is suitable for intramuscular or subcutaneous use, offering broad-spectrum immunity. Ideal for seasonal flu prevention, it is manufactured by Sanofi Winthrop Industrie.

Efluelda Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the B/Michigan/01/2021 virus. This quadrivalent vaccine targets four strains of the flu virus, providing comprehensive protection. It is commonly administered to individuals seeking to reduce the risk of seasonal flu and its associated complications.

After receiving Efluelda Tetra, individuals may experience common effects such as soreness at the injection site, mild fever, or fatigue. These effects are typically temporary and resolve within a few days. The vaccine works by stimulating the immune system to produce antibodies against the flu virus.

Efluelda Tetra should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous flu vaccines or any of its components should consult a healthcare provider before use. It is important to inform your healthcare provider about any current medications or health conditions.

Efluelda Tetra may interact with certain medications or health conditions. It is advisable to discuss any current medications, including immunosuppressants, with a healthcare provider before receiving the vaccine. Alcohol consumption does not typically affect the vaccine's efficacy, but overall health should be considered.